Cessatech A/S (NGM: CESSA)

Market Cap	292.85M
Revenue (ttm)	n/a
Net Income (ttm)	-35.03M
Shares Out	17.43M
EPS (ttm)	-3.83
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,492
Open	11.30
Previous Close	11.30
Day's Range	10.90 - 11.30
52-Week Range	4.05 - 21.39
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 15, 2024

About Cessatech

Cessatech A/S engages in identifying and developing drugs for the treatment of medical unmet need in children in Denmark. The company’s lead product is CT001, an analgesic nasal spray for the treatment of acute and planned painful procedures in children. It also develops CT002, a nasal spray for magnetic resonance imaging scanning; and CT003, a local anesthetic gel. The company has a collaboration and license agreement with Ventis Pharma Corporation to develop and formulate pain management therapies. Cessatech A/S was incorporated in 2020 and i...

• Industry: Pharmaceutical Preparations
• Founded: 2020
• Employees: 4
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: CESSA

Financial Performance

Financial numbers in DKK